Skin Diseases

Subtype terms (47)

More specific conditions that are subtypes of Skin Diseases in the MeSH hierarchy.

• Acneiform Eruptions

  3 drugs (2 approved, 1 experimental)

• Angiolymphoid Hyperplasia with Eosinophilia
• Breast Diseases

  74 drugs (62 approved, 12 experimental)

• Calcinosis Cutis
• Cutaneous Fistula
• Dermatitis

  56 drugs (38 approved, 18 experimental)

• Dermatomyositis

  73 drugs (43 approved, 30 experimental)

• Erythema

  42 drugs (28 approved, 14 experimental)

• Exanthema

  28 drugs (25 approved, 3 experimental)

• Facial Dermatoses

  1 drug approved

• Foot Diseases

  5 drugs approved

• Hair Diseases

  2 drugs (1 approved, 1 experimental)

• Hand Dermatoses

  8 drugs (6 approved, 2 experimental)

• Keratoacanthoma

  3 drugs approved

• Keratosis

  16 drugs (8 approved, 8 experimental)

• Leg Dermatoses
• Lipomatosis

  1 drug approved

• Lupus Erythematosus, Cutaneous

  41 drugs (15 approved, 26 experimental)

• Morgellons Disease
• Nail Diseases

  7 drugs (4 approved, 3 experimental)

• Necrobiotic Disorders
• Necrolytic Migratory Erythema

  1 drug approved

• Nephrogenic Fibrosing Dermopathy

  5 drugs (4 approved, 1 experimental)

• Panniculitis

  2 drugs (1 approved, 1 experimental)

• Photosensitivity Disorders

  10 drugs (7 approved, 3 experimental)

• Pigmentation Disorders

  8 drugs (7 approved, 1 experimental)

• Prurigo

  25 drugs (17 approved, 8 experimental)

• Pruritus

  149 drugs (88 approved, 61 experimental)

• Pyoderma

  6 drugs (2 approved, 4 experimental)

• Rosacea

  70 drugs (45 approved, 25 experimental)

• Scalp Dermatoses

  1 drug approved

• Scleredema Adultorum

  1 drug experimental

• Scleroderma, Localized

  9 drugs (7 approved, 2 experimental)

• Scleroderma, Systemic

  177 drugs (90 approved, 87 experimental)

• Sebaceous Gland Diseases
• Skin Abnormalities

  13 drugs (4 approved, 9 experimental)

• Skin Diseases, Eczematous

  9 drugs (8 approved, 1 experimental)

• Skin Diseases, Genetic

  8 drugs (6 approved, 2 experimental)

• Skin Diseases, Infectious

  44 drugs (38 approved, 6 experimental)

• Skin Diseases, Metabolic
• Skin Diseases, Papulosquamous

  5 drugs (4 approved, 1 experimental)

• Skin Diseases, Vascular
• Skin Diseases, Vesiculobullous

  2 drugs (1 approved, 1 experimental)

• Skin Neoplasms

  164 drugs (98 approved, 66 experimental)

• Skin Ulcer

  10 drugs (5 approved, 5 experimental)

• Sweat Gland Diseases

  7 drugs (6 approved, 1 experimental)

• Xanthogranuloma, Juvenile

  4 drugs (3 approved, 1 experimental)

Drugs by status

Organizations